Search This Blog

Wednesday, July 3, 2024

Israel Takes Out 2nd Senior Hezbollah Commander In Less Than Two Weeks

 Another senior Hezbollah commander has been killed in an Israeli airstrike in southern Lebanon on Wednesday. He was killed in a daytime strike on the coastal city of Tyre, in what appears a neighborhood or city area (according to widely circulating video).

Hezbollah in a statement confirmed the death Muhammad Nimah Nasser, also known as Abu Nimah. Regional reports say that he commanded Hezbollah’s Aziz regional division in southern Lebanon (one of three divisions operating there).

His high rank within the organization is confirmed in the fact that the Hezbollah statement referred to him as a "commander" - which it reserves for only the most senior level operatives.

With the situation already on edge, given both sides are warning that 'all-out war' could be imminent, the marks the second high commander that Israeli has killed in less than two weeks.

Last month a commander named Taleb Abdulla, who headed the Nasr regional division, was taken out in an Israeli strike. Before that, in January the deputy head of the elite Radwan unit Wissam al-Tawil was killed.

The Associated Press reports that "In a video circulated by local media, residents rushed toward a charred vehicle with a large plume of smoke. Civil Defense said its first responders transported an unnamed wounded person to a hospital."

Meanwhile, Israeli Defense Minister Yoav Gallant has told troops during a visit Gaza border that tanks currently completing their tasks in Rafah and now being pulled from the theater can be deployed in the north where they "can reach as far as the Litani" river. The Lebanon river lies 10 miles north of Israel’s border

"We are striking Hezbollah very hard every day and we will also reach a state of full readiness to take any action required in Lebanon, or to reach an arrangement from a position of strength," Gallant said.

"We prefer an arrangement, but if reality forces us we will know how to fight," the IDF chief continued. Israeli leaders have been under immense pressure to act more decisively against Hezbollah, given its daily rocket and drone attacks have meant some 80,000 to 100,000 Israeli residents of the north have been forced out of their homes for months, since near the beginning of the war last October.

https://www.zerohedge.com/geopolitical/israel-takes-out-2nd-senior-hezbollah-commander-less-two-weeks

FDA vaccine regulator shunned COVID booster, warns system lets 'hierarchy overrule science'

 A 30-year veteran of the Food and Drug Administration said at a congressional hearing this week he resigned in part because top brass sidelined his office to rush the full approval of Pfizer's COVID-19 vaccine in August 2021, apparently to legally enable a vaccine mandate, then a booster under emergency use authorization over the objections of the agency's outside advisers.

But former Office of Vaccines Research and Review Deputy Director Philip Krause perhaps saved his biggest embarrassment to the FDA for the end of Wednesday's hearing on alleged Biden administration political interference in COVID vaccine review: He declined the booster.

Krause didn't explain his personal choice to the House Judiciary Administrative State Subcommittee – a disclosure prompted by Chairman Thomas Massie, R-Ky. – but gave both parties ammunition against each other's COVID narratives.

He said primary-series vaccination provided a "very strong benefit" against COVID complications versus risk of adverse events, but "very good studies" showed natural immunity was even more protective. By contrast, boosters were beneficial to "many" people, "especially in the elderly and the immunocompromised."

Early vaccination data showing a "quite high" 1-in-5,000 rate of heart inflammation in young men gave "pause" to Krause and his boss, Director Marion Gruber, he said. Even though most cases are "mild," he said worse cases of myocarditis have lifelong consequences, such as difficulty playing sports.

Krause's testimony includes examples as recently as last week of "a senior leader interfering with the usual review process or single-handedly overruling the scientific recommendation of review teams," he said. "The system is set up to permit hierarchy to overrule science," and one fix is requiring leaders to cite the "support of outside experts" to overrule review teams.

Rep. Hank Johnson, D-Ga., asked whether Krause was a disgruntled employee to blunt his allegations against then-Commissioner Janet Woodcock and Center for Biologics Evaluation and Research Director Peter Marks, saying he was "passed over" for Gruber's job. 

"There was no hat [in the ring], there was no search," Krause shot back, saying he and Gruber resigned on "essentially the same day" in November 2021. Johnson thanked him for his public service.

Nearly half of Tuesday's 623-page interim GOP staff report is transcribed interviews with Krause and Gruber, plus their combative communications with Woodcock and Marks for demanding an "unprecedented" approval timeline that risked "cutting corners" and harming public trust.

One of Gruber's concerns about rushing Biologics License Application approval for Pfizer was the requisite "pediatric plan," since its efficacy trials didn't include children under 12 and safety is "more paramount" in younger groups, Massie said, recounting her interview.

While Gruber told GOP staff she opposed booster authorization for the general public, she didn't leave out of disagreement with that policy but because she had already delayed her planned retirement from June 2020 to help with COVID. She said Krause "didn't want to let me go" and announced less than a week later he was leaving.

Massie opened the hearing with a Pfizer commercial in which the celebrity cooking host Martha Stewart claimed she got boosted because it "help[s] protect against recent Omicron variants" – for which Pfizer had no data – and showed it later to ask witnesses whether it complied with legal requirements to stick to FDA-approved claims.

"It does seem like something is missing here," Krause said. Vaccine-injury lawyer Aaron Siri said the FDA ignored his complaint about that ad and others – one was shown on "Sesame Street" – for lacking disclaimers on products not yet licensed as "safe and effective."

Marks made claims "not vetted" by the FDA in his dozens of "Just a Minute" videos promoting COVID vaccines, Massie said. 

Microvascular Research Foundation founder and doctor Jordan Vaughn, whose Birmingham, Ala. clinic serves many military patients, said young male service members came in shortly after vaccination with "shortness of breath, myocarditis" and "basically are now being medically discharged because they're unable to complete their physical requirement."

Vaughn has seroprevalence records for about 7,000 patients, and until Omicron the reinfection rate among the previously infected was "basically zero," he said.

Unknown physicians reported Vaughn to the Board of Medicine for saying vaccination "did not necessarily prevent transmission," requiring him to have a "discussion" with the regulator, Vaughn said, "but at that time it was proven that I was correct." The same happened when he spoke against masking children at the school board, he said.

The Department of Health and Human Services is "structurally conflicted" because it evaluates safety and promotes vaccines, defending companies against consumers, Siri said. 

Marks' office considers COVID vaccine trials "robust" because they were more reliable than those for most of the childhood vaccine schedule, he also said. They are "anemic" by contrast with most drug trials, which happen over years with placebo controls because, unlike vaccine makers, other drug makers can be held liable for injuries, he said.

One of his clients, 15-year-old Maddie de Garay, is now in a wheelchair with a feeding tube because of Pfizer's trial on her age group, which the company reported as "functional abdominal pain, that she had a tummy ache," Siri said. After several letters to the FDA about her case, "they shrugged and whitewashed" the injury, he claimed.

Even as they denounced purported COVID misinformation from the GOP and witnesses, Democrats and their witness made their own questionable statements.  

Ranking Member Lou Correa, D-Calif., faulted Republicans for "hyper-focusing on the potential misstatements" about COVID vaccines and held up a chart of "misrepresentations and untruths," including that vaccines don't stop infection or transmission.

"We have the responsibility to all Americans to shoot down conspiracy theories, misstatements that can cause grave harm," Correa said. "Another piece of misinformation is that natural immunity isn't real," Massie retorted.

Judiciary Committee Ranking Member Jerry Nadler, D-N.Y., inexpliably claimed that "every witness [Republicans] brought in" testified the vaccine review was "complete, thorough and scientifically rigorous." 

He may have conflated the initial EUA for COVID vaccines in the Trump administration with the BLA approval for Pfizer's vaccine under President Biden, which Gruber and Krause faulted. Nadler invoked their statements in support of the EUA, which Krause said "blew away" FDA criteria.

Rep. Lucy McBath, D-Ga., claimed that Siri said, "and I quote, 'no children have died from COVID,'" shortly after Siri said a 1,700-death figure invoked by Correa was not based on "reliable" data and that "healthy children" were not among them.

University of Utah pediatrics professor Andrew Pavia, testifying on behalf of the Infectious Diseases Society of America, said "many" of Siri's statements were "patently not correct" while falsely claiming children were never required to get COVID vaccines. Siri shot back that he got a court injunction against a San Diego school district's student mandate.

Correa cited a modeling study by the Commonwealth Fund, a favorite of Democrats in COVID hearings, that speculates COVID vaccines saved 3.2 million lives between December 2020 and November 2022.

"These are just not numbers, folks – these are real people," he said.

https://justthenews.com/government/congress/fda-vaccine-regulator-shunned-covid-booster-warns-system-lets-hierarchy

How to Protect Your Food and Medical Freedoms

 In my previous articles, we looked at the global war on farmers, the organizations pushing for the Great Food Reset, the tactics used to foist these changes on the public, the projects underway to remove your access to healthy, farm-fresh foods, the mRNA, RNA, and DNA gene therapies entering our food supply, and how the One Health agenda threatens to destroy both food freedom and medical freedom. 

So what can we do about it? 

The good news is that there are many things we can do. Some of these solutions may sound extreme or inconvenient. But I am guessing many of you chose wildly inconvenient and deeply courageous paths to protect yourselves, your families, and your patients during the Covid psyop, and to avoid being injected with mRNA shots. The substances you take in through your digestive tract can be just as harmful as those that come through a needle.

Do not give in. Do not comply. Do not take the convenient route. It leads to serfdom.

  1. Get involved. Start speaking up about this issue to the people around you.
  1. Stop eating processed foods. They are an addictive poison and only becoming more poisonous.
  1. Join the movement to defund and disband the USDA, the FDA, and your state’s Department of Agriculture. Support bills that limit their power.
  1. Abandon the grocery store. At a minimum, aim to spend at least 50% of your food budget on food direct from local farms.
  1. Find local farms whose husbandry practices meet your requirements. Tour the farm and ask questions – what pesticides do you use? Do you vaccinate your animals? Are your cows 100% grass-fed? Where do you source your feed grains? Do you put any additives in your raw milk, and do you process your own meat? What chemicals are used in your meat processing? When you find a compatible farm, aim to purchase as much of your food as possible from them. You can find local farms at localharvest.org or through a local chapter of the Weston A Price Foundation. If you can’t find compatible farms locally, you can find farms that will deliver to your area at FarmMatch.com.
  1. Support raw milk farmers in your state, and defend their right to produce it, even if you don’t personally drink raw milk. The government bureaucrats view raw milk as the tip of the food freedom spear and believe that if they lose the battle against raw milk, they could lose the food freedom battle entirely. Let’s prove them right. If you want to find a local source of raw milk, visit getrawmilk.com.
  1. Build a local parallel society of like-minded people committed to supporting local food producers and looking out for each other in the challenging times ahead. This is crucial! When the truly hard times hit, it is too late to begin building community. Develop and strengthen your social bonds now, particularly in your local area.
  1. Vote with your wallet while you still have that option. Use cash when you can to prevent your purchases from being tracked and used against you. If your local farmer will take payment in non-fiat currency, even better.
  1. When a retail central bank digital currency launches and cash is phased out, or when states begin to crack down on food purchases that violate the planetary health paradigm, we’re going to need to be ready to transact in alternate currencies. It’s time to start brainstorming and testing payments in cryptocurrencies, pre-1965 silver quarters and dimes (known as junk silver), or by barter. Be creative and get started now. 
  1. Plant your own garden. Study permaculture. It’s a lot easier to ramp up an existing garden with the knowledge you have gained from years of trial and error than it is to start from scratch when you really need it.
  1. Create your own seed vault of heirloom, non-GMO seeds. You can buy them or save seeds from your garden every year. Buy heirloom seeds from trustworthy sources like True Leaf Market.
  1. Get your own backyard chickens and find a local trustworthy feed source. Ask your local pastured chicken farmer where he gets his feed, or if he’s willing to sell some to you.
  1. Buy a large freezer if you can and stock up on frozen fruits and vegetables from farmers you can trust during the growing season.
  1. If you can’t afford a freezer, you can probably afford a couple of grow lights, seed-starting trays, organic potting soil, and seeds. Grow your own microgreens all winter for a small daily salad. They’re nutritious, taste good, and can be harvested in as little as a week. If you can’t afford that, get seeds and a sprout jar, and grow sprouts.
  1. Don’t blindly trust USDA-inspected meat and eggs. It’s a deep rabbit hole you’re welcome to go down, but eggs are washed with chemicals that leave them porous – absorbing those chemicals like chlorine, ammonia, and peracetic acid – and then the eggs are coated with soybean oil, canola oil, or other toxic seed oils which also absorb into the egg white. Don’t see it on the label? Anything that’s an “industry standard” doesn’t need to be listed on the packaging. For meat, that means your beef, pork, goat, chicken, and turkey are soaked with peracetic acid, GMO citric acid, chlorine, lauric acid, or other chemicals. Many of these substances are banned for food use in Europe yet required here. Amish farmer Amos Miller’s battle with the USDA has largely been about his refusal to spray so-called citric acid on his meat, which the USDA mandates for chicken processed in their slaughterhouses unless you want to use bleach or peracetic acid. You’d be excused for thinking commercial citric acid comes from citrus fruit. Instead, it is made from black mold and GMO corn. It is manufactured in China and then sprayed on almost all meat sold in grocery stores in the United States. Black mold is a known allergen and likely causes autoimmune disease. If feasible, only get your meat from dissident farmers committed to pasture-raised, GMO-free, vaccine-free meat and poultry who process meat without chemical additives.
  1. If you feel you can’t afford food like this, consider where your money is going, and if you can rearrange your priorities. It is possible you can barter labor for food with your local farmer. Be prepared to work hard. Also, recognize that the money you spend on truly nutritious food is money you won’t be spending later on medical bills. 
  1. Constitutional sheriffs have played a key role in protecting farmers in several states when bureaucrats attempted to shut them down for selling raw milk and processing their own meat. If you live in a state that still recognizes the constitutional role of sheriffs, get to know your county’s sheriff and find out if he is willing to support the rights of local farms against state and federal agencies. If he is not, find someone to run against him who will. 
  1. Call your congressman and senators to ask them to co-sponsor the PRIME Act. This bill would not fix everything, but it would remove many of the federal obstacles to pushing for agricultural reforms on a state and local level.
  1. Spread the word to everyone you know about what is happening to our food supply. If we all refuse to comply, the scheme is guaranteed to fail.

We are at a crossroads: if we fight now, we can build a future where local farm-to-table networks feed us, and where we choose for ourselves what we want to put in our bodies. If we ignore the plan set out by the global elites for control of our bodies through diet, injections, and injunctions, we do so at great peril. Your health and your family’s health are at stake. Please join the movement to protect both medical freedom and food freedom, as we fight to hold fast to these fundamental rights for future generations.

Tracy Thurman is an advocate for regenerative farming, food sovereignty, decentralized food systems, and medical freedom. She works with the Barnes Law Firm's public interest division to safeguard the right to purchase food directly from farmers without government interference.

https://brownstone.org/articles/how-to-protect-your-food-and-medical-freedoms/

House Democratic leadership to hold call as anxiety over Biden rises

 House Democratic leadership is set to hold a call this afternoon, two sources familiar with the matter confirmed to The Hill, as anxiety rises over President Biden’s standing as the party’s presumptive nominee.

The call — scheduled for 5 p.m. EDT — will include Democratic leadership and members of the Democratic Policy and Communications Committee, one of the sources said. Punchbowl was first to report the call.

The discussion comes as questions — and concerns — are rising about Biden’s ability to remain at the top of the Democratic Party’s ticket after his lackluster debate performance last week.

Rep. Lloyd Doggett (Texas) on Tuesday became the first sitting Democratic lawmaker to call on Biden to step aside from the ticket, breaking the wall of public support the president had enjoyed among congressional Democrats in the aftermath of the debate. When asked about other lawmakers in the caucus following suit, another House Democrat told The Hill, “I would think but not sure.”

Shortly after Doggett’s statement, moderate Democratic Reps. Jared Golden (Maine) and Marie Gluesenkamp Perez (Wash.) said they believed former President Trump would beat Biden in November, chipping away at the party’s confidence in their party’s presumptive nominee.

Biden and his team, to be sure, have consistently said the president is up for another four years in office, brushing off last week’s debate as a poor performance by the commander in chief.

“He knows how to do the job, not because he says it, because his record proves it. Because for three and a half years, almost four years, the president’s record has been unprecedented, delivering for the American people,” White House press secretary Karine Jean-Pierre said Wednesday.

House Democratic leadership and veteran members of the caucus have been also supportive of Biden to this point, though cracks have emerged. House Minority Leader Hakeem Jeffries (D-N.Y.) told reporters last week that he does not think Biden should step aside, but later he said, “Until he articulates a way forward in terms of his vision for America at this moment, I’m gonna reserve comment about anything relative to where we are at this moment other than to say I stand behind the ticket.”

Former Speaker Nancy Pelosi (D-Calif.), meanwhile, has expressed support for Biden, but she did tell MSNBC’s Andrea Mitchell on Tuesday it is “legitimate” to ask both candidates “is this an episode or is this a condition,” prompting speculation about her confidence in the candidate. Later in the day, her spokesperson Ian Krager said, “Speaker Pelosi has full confidence in President Biden and looks forward to attending his inauguration on January 20, 2025.”

Adding to speculation regarding Biden’s standing as the nominee, The New York Times reported Wednesday that the president told an ally that he is unsure if he can salvage his candidacy after last week’s shaky debate performance. The White House, however, refuted the report.

“That claim is absolutely false. If the New York Times had provided us with more than 7 minutes to comment we would have told them so,” White House spokesperson Andrew Bates told The Hill.

https://thehill.com/homenews/house/4754170-house-democrat-leadership-call-biden/

'Zelensky challenges Trump to release plan to end Ukraine war with Russia'

 Ukrainian President Volodymyr Zelensky is challenging former President Trump to release a plan for ending the ongoing war with Russia.

“If Trump knows how to finish this war, he should tell us today,” Zelensky said in a Bloomberg Television interview on Wednesday. “If there are risks to Ukrainian independence, if we lose statehood — we want to be ready for this, we want to know.”

Zelensky said in the interview that he was “potentially ready” to meet with Trump to hear his proposal, according to Bloomberg.

Trump has repeatedly claimed that he could end Russia’s war in Ukraine in just 24 hours if he were the president. Zelensky has responded to that promise and has extended an invitation to Trump numerous times for him to visit war-torn Ukraine.

The former president has also praised Russian President Vladimir Putin in the past, calling him a “genius” shortly after the invasion of Ukraine in 2022. During the presidential debate last week, Trump criticized the amount of funding the U.S. has sent to Ukraine, adding that the country is “not winning the war.”

“I’m only saying, the money that we’re spending on this war, and we shouldn’t be spending, it should have never happened. I will have that war settled between Putin and Zelensky as president-elect before I take office on January 20th. I’ll have that war settled,” Trump said.

Zelensky also pushed back on the idea that the war is in a “deadlock” and suggested that Ukraine needs more resources to help them in the war, Bloomberg reported.

“It’s not a deadlock, it’s a problematic situation,” he said, according to Bloomberg. “A deadlock means there’s no way out. But a problem can be solved if one has the will and has the tools. We do have the will, and the tools — they haven’t arrived yet.”

https://thehill.com/policy/international/4754143-zelensky-trump-ukraine-plan/

Kamada started at Buy by Stifel

 Target $18

https://finviz.com/quote.ashx?t=KMDA&ty=c&ta=1&p=d

Weight-loss drugs linked to rare vision loss: Harvard study

 Novo Nordisk (NVO) and Eli Lilly (LLY) shares dip in reaction to a Harvard study that found GLP-1 weight-loss drugs Ozempic and Wegovy could be linked to rare cases of vision loss.

Yahoo Finance health reporter Anjalee Khemlani explains the study's findings.


Video Transcript

I want to talk about a different study that's certainly capturing Wall Street's attention today, putting some pressure on the G LP One stock.

Specifically the findings here from a Harvard study.

What can you tell us about this?

Yes.

OK.

So this is an observational study.

So I want to make sure we point that out and it only looked at semaglutide, which we know are the novo nodus G LP one drug.

So this cannot be broadly associated with a these drugs as well.

The reason for the study was just to look at an association with a type of vision loss with use of the GP ones.

Now, if you recall in the past, we've heard many different side effects of these GP ones over the years.

One of them, we recall really starkly was suicide ideation.

They found the FDA and the EU both found no links with the drug.

So this is just another one of those things.

And that was the point the researchers said was just to let people know there has been some thing identified related possibly to this drug and to call for further studies as well.

So that's sort of where we stand on that right now.

All right.

So maybe in the downward pressure that we're seeing in the stock is just a flip here today.

https://finance.yahoo.com/video/weight-loss-drugs-linked-rare-161751809.html

'FOMC Minutes "Vast Majority" Expect Economy To Cool, See Deflationary Effects Of AI'

 Since the last FOMC statement on June 12, oil, gold, stocks, the dollar, and even some of the bond market are higher (in price)...

Source: Bloomberg

The shorter-end of the curve is now lower in yield since the last FOMC, but the long-end still higher (even with today's yield tumble)...

Source: Bloomberg

The US macro picture has deteriorated even more significantly relative to expectations, now at its weakest since Dec 2015...

Source: Bloomberg

And thanks to today's macro weakness, rate-cut expectations have risen back to the same levels they were immediately after Powell's press conference...

Source: Bloomberg

So, given the hawkish shift in the DOTS, what does The Fed want us to know from today's Minutes.

Here are the key takeaways from minutes of the Federal Reserve's June 11-12 meeting, released Wednesday (via Bloomberg):

Willing to wait...

Officials did not expect it would appropriate to lower borrowing costs until “additional information had emerged to give them greater confidence” that inflation was moving toward their 2% goal

Economic expectations...

The “vast majority” of Fed officials assessed that economic growth “appeared to be gradually cooling...

...and most participants remarked that they viewed the current policy stance as restrictive”

Officials said inflation progress was evident in smaller monthly gains in the core personal consumption expenditures price index and supported by May consumer price data that were released hours before the rate decision

They appear set of the narrative that AI will save the world too (through deflation)...

Participants highlighted a variety of factors that were likely to help contribute to continued disinflation in the period ahead. The factors included continued easing of demand–supply pressures in product and labor markets, lagged effects on wages and prices of past monetary policy tightening, the delayed response of measured shelter prices to rental market developments, or the prospect of additional supply-side improvements.

The latter prospect included the possibility of a boost to productivity associated with businesses’ deployment of artificial intelligence–related technology. Participants observed that longer-term inflation expectations had remained well anchored and viewed this anchoring as underpinning the disinflation process. Participants affirmed that additional favorable data were required to give them greater confidence that inflation was moving sustainably toward 2 percent

But The Fed seems divided on how to 'react' to data (markets or macro)...

Some officials emphasized the need for patience in allowing high rates to continue to restrain demand...

...while others noted that if inflation were to remain elevated or increase further, rates “might need to be raised”

A “number” of officials said the Fed needs to stand ready to respond to unexpected weakness, and several flagged that a further drop in demand may push up unemployment rather than just reduce job openings

WSJ Fed-Watcher Nick Timiraos chimes in to confirm the more dovish bias of the Minutes...

Read the full Minutes below:


'Wage growth nears three-year low in June as labor market enters 'different regime''

 Pay increases for American workers have continued to fall from highs reached during the post-pandemic reopening.

And that's as true for folks keeping the same job as it is for those finding a new gig.

According to new data from ADP released Wednesday, annual wage increases for workers who stayed in their same job increased at the slowest rate in nearly three years in June. For job changers, annual wage increases slid for a third straight month.

"We are in a different regime than we've been in the past where that job-stayer growth was either flat or even rising," ADP chief economist Nela Richardson said during a call with reporters on Wednesday.

"The question before us is just how low is [it] going to get? The idea that job stayer growth would go back to pre-pandemic levels is still being challenged."

In June, wages for job stayers rose 4.9% from the prior year, slower than the 5% pace seen in the prior month and the slowest growth since August 2021. Wages for workers who changed jobs increased 7.7% year over year, down from 7.8% the month prior and well below the 16.4% seen at its peak in June 2022.

Read more: How does the labor market affect inflation?

Richardson noted that the still-elevated pay gains for job switchers reflect there is still some tightness in the labor market amid other signs of slowing, a trend among a slew of recent labor market data.

New data from the Bureau of Labor Statistics released Tuesday, for instance, showed there were 8.14 million jobs open at the end of May, an increase from the 7.92 million job openings in April.

Overall, labor market data has largely shown continued signs of moving off the boil but not entering a rapid cooldown. Richardson reasoned a similar trend is playing out in ADP's data. The ADP Research Institute's National Employment Report showed 150,000 jobs were added to the private sector in June, a deceleration from the 157,00 job additions in May.

Richardson noted that a range of about 120,000 to 150,000 monthly job additions keeps the labor market in a sweet spot, where it's not flashing warning signs about a slowdown in the US economy but not overheating the economy, either.

And to Richardson, the real concern would be a sudden decrease in job gains.

"It's the rate in which the economy evolves, not necessarily the level," Richardson said.

"And if we see the cooldown go from gradual to steep, I think that's a warning bell."

With the unemployment rate at its highest level in more than two years and continuing unemployment benefit claims rising each week, economists remain wary of the labor market's trajectory.